-
Product Insights
NewNet Present Value Model: Passage Bio Inc’s PBGM-01
Empower your strategies with our Net Present Value Model: Passage Bio Inc's PBGM-01 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: Passage Bio Inc’s PBFT-02
Empower your strategies with our Net Present Value Model: Passage Bio Inc's PBFT-02 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval Analysis for Respiratory Tract Infections
Overview How likely is it that the drugs in Respiratory Tract Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Respiratory Tract Infections Overview Respiratory tract infections (RTIs) are infectious diseases...
-
Product Insights
NewLikelihood of Approval Analysis for Sinusitis
Overview How likely is it that the drugs in Sinusitis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sinusitis Overview Sinusitis is characterized by inflammation of the sinuses. This inflammation usually...
-
Product Insights
NewLikelihood of Approval Analysis for Cystic Fibrosis
Overview How likely is it that the drugs in Cystic Fibrosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cystic Fibrosis Overview Cystic fibrosis (CF) is an inherited disease that causes...
-
Product Insights
NewLikelihood of Approval Analysis for Upper Respiratory Tract Disorders
Overview How likely is it that the drugs in Upper Respiratory Tract Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Upper Respiratory Tract Disorders Overview Upper respiratory infection (URI) is...
-
Product Insights
NewLikelihood of Approval Analysis for Cough
Overview How likely is it that the drugs in Cough will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cough Overview A cough is a sudden expulsion of air through the large...
-
Product Insights
Calavite Passage Offshore Wind Project
Calavite Passage Offshore Wind Project is an offshore wind project located in Philippine Sea, Philippines. The project is owned and being developed by Alternergy Philippines Holding Corp; Shell Overseas Investments BV. The project is expected to come online in 2029. Empower your strategies with our Calavite Passage Offshore Wind Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day...
-
Product Insights
NewNet Present Value Model: Teva Pharmaceutical Industries Ltd’s Omalizumab Biosimilar
Empower your strategies with our Net Present Value Model: Teva Pharmaceutical Industries Ltd's Omalizumab Biosimilar report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PBFT-02 in Frontotemporal Dementia (FTD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PBFT-02 in Frontotemporal Dementia (FTD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PBFT-02 in Frontotemporal Dementia (FTD) Drug Details: PBFT-02 is under...